Clinical Trials Browser

Phase 3 × Stomach Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT06346392 2026-03-09

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT02500043 2024-09-03

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

Phase 3 Completed

507 enrolled 17 charts 1 FDA

Gastrointestinal

Stomach Neoplasms